St. Jude Gets Nod for Vascular Closure Device

St. Jude Medical received FDA and CE Marking approval of the Angio-Seal Evolution vascular closure device. The device enables physicians to seal femoral artery punctures made during minimally invasive, catheter-based procedures. It differs from similar devices in that the system is fully absorbed by the body within 60 to 90 days. This reduces risks associated with foreign material left permanently in the body and allows for repeat procedures without concern over the prior placement of closure devices, St. Jude said.